CAMBRIDGE, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that it will webcast its presentations at the JPMorgan Small/Mid Cap Conference on Monday, November 13, 2006 at 10:15 a.m. EST; the Credit Suisse Phoenix Healthcare Conference on Thursday, November 16, 2006 at 12:00 p.m. MST (2:00 p.m. EST); and at the Piper Jaffray 18th Annual Health Care Conference on Wednesday, November 29, 2006 at 1:30 p.m. EST.
Each presentation will be webcast live and may be accessed under the "Investors" tab at http://www.vrtx.com/. A replay of the webcasts will also be available on Vertex's website for two weeks following the presentations. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline. Lexiva is a registered trademark of the GlaxoSmithKline group of companies. Vertex's press releases are available at http://www.vrtx.com/.
Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755 DATASOURCE: Vertex Pharmaceuticals Incorporated CONTACT: Lora Pike, Manager, Investor Relations of Vertex, +1-617-444- 6755 Web site: http://www.vrtx.com/ Company News On-Call: http://www.prnewswire.com/comp/938395.html
|